Lexaria Bioscience (LEXX) Operating Margin Growth (3y) (2020 - 2026)
Lexaria Bioscience (LEXX) Operating Margin Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -377.00 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -204.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | -537.00 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -1,934.00 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 7,261.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 9,003.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -11,254.00 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 30,461.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -2,649.00 |
| 10 | Lexaria Bioscience | 10.15 Mn | 6.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -64,965.00 |
| Aug 31, 2025 | -87,171.00 |
| May 31, 2025 | 26,979.00 |
| Feb 28, 2025 | 314,546.00 |
| Nov 30, 2024 | 1.30 Mn |
| Aug 31, 2024 | 157,661.00 |
| May 31, 2024 | -81,713.00 |
| Feb 29, 2024 | 11,456.00 |
| Nov 30, 2023 | -80,007.00 |
| Aug 31, 2023 | -227,589.00 |
| May 31, 2023 | 78,227.00 |
| Feb 28, 2023 | -378,242.00 |
| Nov 30, 2022 | 771,270.00 |
| Aug 31, 2022 | 21,846.00 |
| May 31, 2022 | -44,303.00 |
| Feb 28, 2022 | 278,611.00 |
| Nov 30, 2021 | -1.13 Mn |
| Aug 31, 2021 | -292,568.00 |
| May 31, 2021 | 118,266.00 |
| Feb 28, 2021 | 22,633.00 |